Dr Neil Murphy is a cancer epidemiologist in the Department of Epidemiology and Biostatistics at Imperial College, London. He received a BSc in Nutrition from King’s College London, and an MSc in Modern Epidemiology and PhD in Epidemiology from Imperial College London. Dr Murphy has a major interest in understanding the aetiological mechanisms underlying the development of cancer. He has recently begun a portfolio of research aimed at investigating the metabolic and endocrinological influences on colorectal cancer, and has taken the lead in analyses of data from European and U.S. prospective cohort studies, including the European Prospective Investigation into Cancer and Nutrition (EPIC), UK Biobank, Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial, and the Women's Health Initiative (WHI).
et al., 2021, Testosterone, sex hormone-binding globulin, insulin-like growth factor-1 and endometrial cancer risk: observational and Mendelian randomization analyses., Br J Cancer
et al., 2021, Circulating tryptophan metabolites and risk of colon cancer: Results from case-control and prospective cohort studies, International Journal of Cancer, ISSN:0020-7136
et al., 2021, Genetic architectures of proximal and distal colorectal cancer are partly distinct, Gut, Vol:70, ISSN:0017-5749, Pages:1325-1334
et al., 2021, Genetically predicted circulating concentrations of micronutrients and risk of colorectal cancer among individuals of European descent: a Mendelian randomization study, American Journal of Clinical Nutrition, Vol:113, ISSN:0002-9165, Pages:1490-1502
et al., 2021, Causal effects of lifetime smoking on breast and colorectal cancer risk: Mendelian randomization study, Cancer Epidemiology, Biomarkers and Prevention, Vol:30, ISSN:1055-9965, Pages:953-964